首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1573886

過敏免疫治療市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Allergy Immunotherapy Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月29日 | 出版商:

Global Market Insights Inc. | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球過敏免疫治療市場價值為 19 億美元，預計在整個預測期內複合年成長率為 8.5%。這一成長主要是由全球過敏症盛行率不斷上升所推動的，這凸顯了對過敏免疫療法等有效治療方案的迫切需求。

推動市場擴張的一個重要因素是醫療保健支出的增加和消費者對先進治療的認知不斷增強。處方藥的創新帶來了更有針對性的治療，增加了患者的可及性和便利性。研究也致力於開發可以同時針對多種過敏原的先進治療方法，提高療效並擴大患者的治療選擇。預計這些進步將對未來幾年的過敏免疫療法市場產生積極影響。

過敏免疫療法，也稱為低敏或脫敏，是一種旨在透過緩慢增加患者對不同過敏原的耐受性來減輕過敏症狀的醫療方法。這種治療包括透過舌下免疫治療 (SLIT) 片劑或滴劑或皮下免疫治療 (SCIT) 注射，使患者接觸逐漸增加劑量的過敏原。

過敏免疫治療市場根據治療類型可分為 SCIT 和 SLIT，其中 SCIT 細分市場將在 2023 年領先市場，規模達 11 億美元。 SCIT 已廣泛使用多年，其功效已得到充分研究並為醫療保健提供者所熟悉。它有效地針對多種過敏原，包括塵蟎、花粉和昆蟲毒液，使其成為多種過敏患者的多功能選擇。此外，眾所周知 SCIT 可以誘導強烈的免疫反應，使其成為嚴重過敏病例的首選。

依過敏類型分類，市場包括過敏性鼻炎、氣喘、皮膚過敏、食物過敏等。由於其高盛行率，過敏性鼻炎細分市場在 2023 年佔據了主導市場。

從分銷管道來看，市場分為醫院、零售和線上藥房，預計到2032年醫院藥房將達到21億美元。

2023年，北美是過敏免疫治療的最大市場，收入為7.805億美元。這種主導地位是由於該地區發達的醫療保健系統、過敏症盛行率高以及有利的監管環境，促進了新療法的快速採用。美國市場特別受益於強大的醫療基礎設施和研究進步，確保其在過敏免疫治療領域的持續領先地位。

產業生態系統分析
產業影響力
- 成長動力
  - 過敏性疾病的盛行率不斷增加
  - 舌下劑量免疫療法的進展
  - 擴大產品組合
- 產業陷阱與挑戰
  - 治療費用高
  - 認知度和可近性有限
成長潛力分析
監管環境
管道分析
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按治療類型，2021 - 2032 年

主要趨勢
皮下免疫療法（SCIT）
舌下免疫療法（SLIT）
- 平板電腦
- 滴

第 6 章：市場估計與預測：按過敏類型，2021 - 2032

主要趨勢
過敏性鼻炎
氣喘
皮膚過敏
食物過敏
其他過敏

第 7 章：市場估計與預測：按配銷通路，2021 - 2032 年

主要趨勢
醫院藥房
零售藥房
網路藥房

第 8 章：市場估計與預測：按地區分類，2021 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

Adamis Pharmaceuticals Corporation
Aimmune Therapeutics, Inc.
ALK-Abello A/S
Allergy Therapeutics plc
ASIT Biotech
Circassia Pharmaceuticals plc
DESENTUM OY
DVB Technologies SA
HAL Allergy B.V.
HollisterStier Allergy
LETI Pharma
Merck KGaA
Mylan N.V.
Stallergenes Greer plc
Zhejiang Wolwo Bio-pharmaceutical Co., Ltd.

簡介目錄

Product Code: 11114

The Global Allergy Immunotherapy Market was valued at USD 1.9 billion in 2023 and is projected to grow at an 8.5% CAGR throughout the forecast period. This growth is largely driven by the increasing prevalence of allergies worldwide, highlighting the urgent need for effective treatment options like allergy immunotherapy.

One significant factor contributing to market expansion is the rising healthcare expenditure and growing consumer awareness regarding advanced treatments. Innovations in prescription medications have led to more targeted therapies, increasing patient accessibility and convenience. Research is also focusing on developing advanced treatments that can target multiple allergens simultaneously, enhancing efficacy and expanding treatment options for patients. Such advancements are expected to positively impact the allergy immunotherapy market in the coming years.

Allergy immunotherapy, also known as hypo-sensitization or desensitization, is a medical treatment aimed at alleviating allergic symptoms by slowly increasing a patient's tolerance to distinct allergens. This treatment involves exposing patients to gradually increasing doses of allergens, either through sublingual immunotherapy (SLIT) tablets or drops or subcutaneous immunotherapy (SCIT) injections.

The allergy immunotherapy market can be divided based on treatment type into SCIT and SLIT, with the SCIT segment leading the market in 2023, accounting for USD 1.1 billion. SCIT has been widely used for several years, making its efficacy well-studied and familiar to healthcare providers. It effectively targets a variety of allergens, including dust mites, pollens, and insect venom, making it a versatile option for patients with multiple allergies. Furthermore, SCIT is known to induce a strong immune response, making it the preferred choice for severe allergic cases.

When categorized by allergy type, the market includes allergic rhinitis, asthma, skin allergies, food allergies, and others. The allergic rhinitis segment held a dominant market share in 2023, driven by its high prevalence.

In terms of distribution channels, the market is divided into hospital, retail, and online pharmacies, with hospital pharmacies expected to reach USD 2.1 billion by 2032. Hospital pharmacies are essential for managing specialized allergy immunotherapy medications and ensuring patients receive the appropriate treatment.

North America was the largest market for allergy immunotherapy in 2023, with revenues of USD 780.5 million. This dominance is due to the region's well-developed healthcare system, high prevalence of allergies, and favorable regulatory environment, which facilitates the rapid adoption of new treatments. The U.S. market specifically benefits from strong healthcare infrastructure and research advancements, ensuring its continued leadership in the allergy immunotherapy sector.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of allergic conditions
  - 3.2.1.2 Advancements in sublingual dosage immunotherapy
  - 3.2.1.3 Expanding product portfolio
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of treatment
  - 3.2.2.2 Limited awareness and accessibility
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pipeline analysis
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Treatment Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Subcutaneous immunotherapy (SCIT)
5.3 Sublingual immunotherapy (SLIT)
- 5.3.1 Tablets
- 5.3.2 Drops

Chapter 6 Market Estimates and Forecast, By Allergy Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Allergic rhinitis
6.3 Asthma
6.4 Skin allergy
6.5 Food allergy
6.6 Other allergies

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospital pharmacy
7.3 Retail pharmacy
7.4 Online pharmacy

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa